Predicting liver-related serious adverse events in patients with primary biliary cholangitis-related cirrhosis treated with obeticholic acid

Authors: Londoño MC, Díaz-González Á.
Liver Int. 2022 Nov;42(11):2356-2359. doi: 10.1111/liv.15379. PubMed: 36162085
Mostrar Más
PMID: 36162085
Title: Predicting liver-related serious adverse events in patients with primary biliary cholangitis-related cirrhosis treated with obeticholic acid
Authors: Londoño MC, Díaz-González Á.
Citation: Liver Int. 2022 Nov;42(11):2356-2359. doi: 10.1111/liv.15379.
First Author: Londoño MC
Journal/Book: Liver Int
Publication Year: 2022
Create Date: 2022/09/26
PMCID:
NIHMS ID:
DOI: 10.1111/liv.15379